Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 10, 2005 - Issue 1
Submit an article Journal homepage
491
Views
145
CrossRef citations to date
0
Altmetric
Review

Transgenic plants in the biopharmaceutical market

Richard M Twyman University of York, Department of Biology, Heslington, York YO10 5DD, UK. [email protected]
,
Stefan Schillberg University of York, Department of Biology, Heslington, York YO10 5DD, UK. [email protected]
&
Rainer Fischer University of York, Department of Biology, Heslington, York YO10 5DD, UK. [email protected]
Pages 185-218 | Published online: 22 Apr 2005

Bibliography

  • FISCHER R, EMANS N: Molecular farming of pharmaceutical proteins. Transgenic Res. (2000) 9(4-5):279–299.
  • RASKIN I, RIBNICKY DM, KOMRNYTSKY S et al.: Plants and human health in the twenty-first century. Trends Biotechnol (2002) 20(12):522–531.
  • BARTA A, SOMMERGRUBER K, THOMPSON D, HARTMUTH K, MATZKE M, MATZKE A: The expression of a nopaline synthase human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Md. Biol. (1986) 6(5):347–357.
  • SIJMONS PC, DEKKER BMM, SCHRAMMEIJER B, VERWOERD TC, VAN DEN ELZEN PJM, HOEKEMA A: Production of correctly processed human serum albumin in transgenic plants. Bio/. Technol (1990) 8(3):217–221.
  • TWYMAN RM, STOGER E, SCHILLBERG S, CHRISTOU P, FISCHER R: Molecular farming in plants: host systems and expression technology. Trends Biotechnol. (2003) 21(12):570–578.
  • •This review provides a comprehensive guide to the production of pharmaceuticals in plants, including a detailed description of all the available host systems for protein expression.
  • FISCHER R, STOGER E, SCHILLBERG S, CHRISTOU P, TWYMAN RM: Plant based production of biopharmaceuticals. Curr. Opin. Plant Biol. (2004) 7(2):152–158.
  • MA JKC, DRAKE P, CHRISTOU P: The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. (2003) 4(10):794–805.
  • •This review provides a comprehensive guide to the production of pharmaceuticals in plants, including a detailed description of all the available host systems for protein expression.
  • DANIELL H, STREATFIELD SJ, WYCOFF K: Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. (2001) 6(5):219–226.
  • GIDDINGS G: Transgenic plants as protein factories. Curr. Opin. Biotechnol (2001) 12(5):450–454.
  • HOOD EE, WITCHER DR, MADDOCK S et al.: Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Md. Breeding (1997) 3(4):291–306.
  • WITCHER DR, HOOD EE, PETERSON D et al.: Commercial production of B-glucuronidase (GUS): a model system for the production of proteins in plants. MoL Breeding (1998) 4(4):301–312.
  • ANDERSEN DC, KRUMMEN L: Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol (2002) 13(2):117–123.
  • CHOI JH, LEE SY: Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl MicrobioL Biotechnol. (2004) 64(5):625–635.
  • BANEYX F, MUJACIC M: Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. (2004) 22(11):1399–1408.
  • SIMMONS LC, YANSURA DG: Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli. Nat. Biotechnol. (1996) 14(5):629–634.
  • JEONG KJ, LEE SY: Secretory production of human leptin in Escherichia coli. Biotechnol. Bioeng. (2000) 67(4):398–407.
  • BESSETTE PH, ASLUND F, BECKWITH J, GEORGIOU G: Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl. Acad. Sci. USA (1999) 96(2013703–13708.
  • ROMANOS MA, SCORER CA, CLARE JJ: Foreign gene expression in yeast: a review. Yeast (1992) 8(6):423–488.
  • VALENZUELA P, MEDINA A, RUTTER WJ, AMMERER G, HALL BD: Synthesis and assembly of hepatits B virus surface antigen particles in yeast. Nature (1982) 298(5872):347–350.
  • DOMINGUEZ A. FERMINAN E, SANCHEZ M et al.: Non-conventional yeasts as hosts for heterologous protein production. Int. Microbiol. (1998) 1(2):131–142.
  • CHIBA Y, SUZUKI M, YOSHIDA S et al: Production of human compatible high mannose-type (Man5G1cNAc2) sugar chains in Saccharomyces cerevisiae. J. Biol. Chem. (1998) 273(41):26298–26304.
  • CEREGHINO GPL, CEREGHINO JL, ILGEN C, GREGG JM: Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr. Opin. Biotechnol. (2002) 13(4):329–332.
  • CHOI BK, BOBROWICZ P, DAVIDSON RC et al: Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc. Natl Acad. Sci. USA (2003) 100(9):5022–5027.
  • PUNT PJ, VAN BIEZEN N, CONESA A, ALBERS A, MANGNUS J, VAN DEN HONDEL C: Filamentous fungi as cell factories for heterologous protein production. Trends Biotechnol (2002) 20(5):200–206.
  • RADZIO R, KFICK U: Synthesis of biotechnologically relevant heterologous proteins in filamentous fungi. Process Biochem. (1997) 32(6):529–539.
  • GERNGROSS TU: Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol (2004) 22(11):1409–1414.
  • CHU L, ROBINSON DK: Industrial choices for protein production by large scale cell culture. Curr. Opin. Biotechnol (2001) 12(2):180–187.
  • WURM FM: Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol (2004) 22(11):1393–1398.
  • GRABENHORST E, SCHLENKE P, POHL S, NIMTZ M, CONRADT HS: Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconjugate J. (1999) 16(2):81–97.
  • HOUDEBAINE LM: Transgenic animal bioreactors. Transgenic Res. (2000) 9(4-5):305–320.
  • KEEFER CL: Production of bioproducts through the use of transgenic animal models. Anim. Reprod. Sci. (2004) 82–83:5–12.
  • DYCK MK, LACROIX D, POTHIER F, SIRARD MA: Making recombinant proteins in animals - different systems, different applications. Trends Biotechnol. (2003) 21(9):394–399.
  • WALL RJ: Biotechnology for the production of modified and innovative animal products: transgenic livestock bioreactors. Livestock Prod. Sci. (1999) 59(2-3):243–255.
  • POLLOCK D, KUTZKO J, BIRCK-WILSON E, WILLIAMS J, ECHELARD Y, MEADE H: Transgenic milk as a method for the production of recombinant antibodies. J. Immunol Methods (1999) 231(1-2):147–157.
  • HARVEY AJ, SPEKSNIJDER G, BAUGH LR, MORRIS JA, IVARIE R: Expression of exogenous protein in the egg white of transgenic chickens. Nat. Biotechnol (2002) 20(4):396–399.
  • CHADD HE, CHAMOW SM: Therapeutic antibody expression technology. Curr. Opin. Biotechnol (2001) 12(2):188–194.
  • RAJU TS, BRIGGS J, BORGE SM, JONES AJS: Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology (2000) 10(5):477–486.
  • IKONOMOU L, SCHNEIDER YJ, AGATHOS SN: Insect cell culture for industrial production of recombinant proteins. Appl. Microbiol Biotechnol. (2003) 62(1):1–20.
  • FRASER MJ: The baculovirus-infected insect cell as a eukaryotic gene expression system. Curr. Top. Microbiol Immunol (1992) 158:131–172.
  • KOST TA, CONDREAY JP: Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr. Opin. Biotechnol. (1999) 10(5):428–433.
  • McCARROLL L, KING LA: Stable insect cell cultures for recombinant protein production. Curr. Opin. Biotechnol (1997) 8(5):590–594.
  • FARRELL PJ, BEHIE LA, IATROU K: Transformed lepidopteran insect cells: new sources of recombinant human tissue plasminogen activator. Biotechnol. Bioeng. (1999) 64(4):426–433.
  • MARCHAL I, JARVIS DL, CACAN R, VERBERT A: Glycoproteins from insect cells: sialated or not? Biol. Chem. (2001) 382(2):151–159.
  • JARVIS DL, HOWE D, AUMILLER JJ: Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopeteran insect cells. Wrol. (2001) 75(13):6223–6227.
  • TOMITA M, MUNETSUNA H, SATO T et al.: Transgenic silkworms produce recombinant human Type III procollagen in cocoons. Nat. Biotechnol (2003) 21(1):52–56.
  • MASON HS, WARZECHA H, MOR T, ARNTZEN CJ: Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med. (2002) 8(7):324–329.
  • PERRIN Y, VAQUERO C, GERRARD I et al: Transgenic pea seeds as bioreactors for the production of a single-chain Fv fragment (scFv) antibody used in cancer diagnosis and therapy. MoL Breeding (2002) 6(4):345–352.
  • STOGER E, VAQUERO C, TORRES E et al: Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Md. Biol. (2000) 42(4):583–590.
  • LIU JH, SELINGER LB, CHENG KJ, BEAUCHEMIN KA, MOLONEY MM: Plant seed oil bodies as an immobilization matrix for a recombinant xylanase from the rumen fungus Neocallimastix patriciarum. MoL Breeding (1997) 3(6):463–470.
  • SCHILLBERG S, ZIMMERMANN S, FINDLAY K, FISCHER R: Plasma membrane display of anti-viral single chain HT fragments confers resistance to tobacco mosaic virus. Mol Breeding (2000) 6(3):317–326.
  • BORISJUK NV, BORISJUK LG, LOGENDRA S, PETERSEN F, GLEBA Y, RASKIN I: Production of recombinant proteins in plant root exudates. Nat. Biotechnol (1999) 17(5):466–469.
  • •This paper describes the secretion of proteins through the root exudates of hydroponically-grown tobacco plants, providing the means to recover the product continuously and nondestructively from the medium.
  • KOMARNYTSKY S, BORISJUK NV, BORISJUK LG, ALAM MZ, RASKIN I: Production of recombinant proteins in tobacco guttation fluid. Plant Physiol. (2000) 124(3):927–933.
  • DRAKE PMW, CHARGELEGUE DM, VINE ND, VAN DOLLEWEERD CJ, OBREGON P, MA JKC: Rhizosecretion of a monoclonal antibody protein complex from transgenic tobacco roots. Plant Md. Biol. (2003) 52(1):233–241.
  • ••This paper extends the studies described in[511, by using the hydroponic system to secrete antibodies. The surprising result was that most of the antibody was secreted into the medium, even though the large size of the protein should cause it to be trapped in the cell wall matrix.
  • D'AOUST MA, BUSSE U, MARTEL M, LEROUGE P, LEVESQUE D, VEZINA LP: Perennial plants as a production system for pharmaceuticals. In: Handbook ofPlant Biotechnology (Volume 2). Christou P, Klee H (Eds.), Wiley-VCH, NY (2004):759–768.
  • ZEITLIN L, OLMSTED SS, MOENCH TR et al: A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat. BiotechnoL (1998) 16(13):1361–1364.
  • KHOUDI H, LABERGE S, FERULLO JM et al. Production of a diagnostic monoclonal antibody in perennial alfalfa plants. BiotechnoL Bioeng. (1999) 64(2):135–143.
  • BARDOR M, LOUTELIER-BOURHIS C, PACCALET T et al: Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant Biotech. J. (2003) 1(6):451–462.
  • KAPUSTA J, MODELSKA A, FIGLEROWICZ M et al.: A plant-derived edible vaccine against hepatitis B virus. FASEB J. (1999) 13(13):1796–1799.
  • YUSIBOV V, HOOPER DC, SPITSIN S et al.: Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine (2002) 20(25-20:3155–3164.
  • STOGER E, MA JKC, FISCHER R, CHRISTOU P: Pharmaceutical proteins as seed proteins. Cuff. Opin. BiotechnoL (In Press).
  • STOGER E, SACK M, PERRIN Y et al: Practical considerations for pharmaceutical antibody production in different crop systems. MoL Breeding (2002) 9(3):149–1586.
  • TACKET CO, MASON HS, LOSONSKY G, CLEMENTS JD, LEVINE MM, ARNTZEN CJ: Immunogenicity in humans of a recombinant bacterial-antigen delivered in transgenic potato. Nat. Med. (1998) 4(5):607–609.
  • ••This is the first demonstration ofimmunogenicity in humans of a vaccine candidate produced in plants.
  • TACKET CO, MASON HS, LOSONSKY G, ESTES MK, LEVINE MM, ARNTZEN CJ: Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. (2000) 182(1):302–305.
  • RICHTER LJ, THANAVALA Y, ARNTZEN CJ, MASON HS: Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol (2000) 18(11):1167–1171.
  • YU J, LANGRIDGE W: Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res. (2003) 12(2):163–169.
  • ARTSAENKO O, KETTIG B, FIEDLER U, CONRAD U, DURING K: Potato tubers as a biofactory for recombinant antibodies. MoL Breeding (1998) 4(4):313–319.
  • DE WILDE C, PEETERS K, JACOBS A, PECK I, DEPICKER A: Expression of antibodies and Fab fragments in transgenic potato plants: a case study for bulk production in crop plants. MoL Breeding (2002) 9(4):271–282.
  • SCHUNMANN PHD, COIA G, WATERHOUSE PM: Biopharming the SimpliREDTm HIV diagnostic reagent in barley, potato and tobacco. Mol. Breeding (2002) 9(2):113–121.
  • CHONG DKX, LANGRIDGE WHR: Expression of full-length bioactive antimicrobial human lactoferrin in potato plants. Transgenic Res. (2000) 9(1):71–78.
  • CHONG DKX, ROBERTS W, ARAKAWA T et al: Expression of the human milk protein 0-casein in transgenic potato plants. Transgenic Res. (1997) 6(4):289–296.
  • MCGARVEY PB, HAMMOND J, DIENELT MM et al.: Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology (1995) 13(13):1484–1487.
  • •The first demonstration of a widely applicable vaccine candidate produced in plants.
  • WALMSLEY AM, ALVAREZ ML, JIN Y et al.: Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep. (2003) 21(10):1020–1026.
  • SANDHU JS, KRASNYANSKI SF, DOMIER LL, KORBAN SS, OSADJAN MD, BUETOW DE: Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res. (2000) 9(2):127–135.
  • WANG LJ, NI DA, CHEN YN, LEE ZM: The expression of Mycobacterium tuberculosis MPT64 protein in transgenic carrots. Acta Bot. Sin. (2001) 43(2):132–137.
  • PORCEDDU A. FALORNI A, FERRADINI N et al.: Transgenic plants expressing human glutamic acid decarboxylase (GAD65), a major autoantigen in insulin-dependent diabetes mellitus MoL Breeding (1999) 5(6):553–560.
  • BOUCHE FB, MARQUET-BLOUIN E, YANAGI Y, STEINMETZ A, MULLER CP: Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: a novel antigen to protect against measles. Vaccine (2003) 21(17-102065–2072.
  • MARQUET-BLOUIN E, BOUCHE FB, STEINMETZ A, MULLER CP: Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin. Plant Mot Biol. (2003) 51(4):459–469.
  • SALA F, RIGANO MM, BARBANTE A, BASSO B, WALMSLEY AM, CASTIGLIONE S: Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine (2003) 21(7-8):803–808.
  • TYAGI AK: Plant genes and their expression. Curr. Sci. India (2001) 80(2):161–169.
  • CHRISTENSEN AH, QUAIL PH: Ubiquitin promoter-based vectors for high-level expression of selectable and/or screenable marker genes in monocotyledonous plants. Transgenic Res. (1996) 5(3):213–218.
  • COMMANDEUR U, TWYMAN RM, FISCHER R: The biosafety of molecular farming in plants. AgBiotechNet (2003) 5:ABN 110.
  • PADIDAM M: Chemically regulated gene expression in plants. Curr. Opin. Plant Biol. (2003) 6(2):169–177.
  • ••A comprehensive review discussing indetail the biosafety issues surrounding the use of field grown plants for the production of pharmaceuticals.
  • CRAMER CL, BOOTHE JG, OISHI KK: Transgenic plants for therapeutic proteins: linking upstream and downstream technologies. Curr. Top. Microbiol Immunol (1999) 240:95–118.
  • ZIMMERMANN S, SCHILLBERG S, LIAO YC, FISCHER R: Intracellular expression of TMV-specific single-chain HT fragments leads to improved virus resistance in IVicotiana tabacum. Md. Breeding (1998) 4(4):369–379.
  • SCHILLBERG S, ZIMMERMANN S, VOSS A, FISCHER R: Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic Res. (1999) 8(4):255–263.
  • CONRAD U, FIEDLER U: Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Md. Biol. (1998) 38(1-2):101–109.
  • SCHILLBERG S, EMANS N, FISCHER R: Antibody molecular farming in plants and plant cells. Phytochem. Rev. (2002) 1(1):45–54.
  • SRIRAIVIAN R, SACK M, TALWAR GP, FISCHER R: Glycosylation of recombinant antibodies in plants. In: Proceedings of the Ninth Annual Ranbaxy Science Foundation Symposium. Ranbaxy Science Foundation, New Delhi (2003):89–98.
  • DANIELL H, KHAN MS, ALLISON L: Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. (2002) 7(2):84–91.
  • STAUB JM, GARCIA B, GRAVES J et al: High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol (2000) 18(3):333–338.
  • ••The first demonstration of a recombinanttherapeutic protein expressed in chloroplasts. The high expression levels possible using this system were unprecedented.
  • FERNANDEZ-SAN MILLAN A, MINGO-CASTEL A, MILLER M, DANIELL H: A chloroplast transgenic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol J. (2003) 1(2):77–79.
  • DANIELL H, LEE SB, PANCHAL T, WIEBE PO: Expression of the native cholera B toxin subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. j MoL Biol. (2001) 311(5):1001–1009.
  • TREGONING JS, NIXON P, KURODA H et al.: Expression of tetanus toxin fragment C in tobacco chloroplasts. Nucleic Acids Res. (2003) 31(4):1174–1179.
  • HOOD EE, WOODARD SL, HORN ME: Monoclonal antibody manufacturing in transgenic plants - myths and realities. Curr. Opin. Biotechnol (2002) 13(6):630–635.
  • STOGER E, SACK M, FISCHER R, CHRISTOU P: Plantibodies: applications, advantages and bottlenecks. Curr. Opin. Biotechnol (2002) 13(2):161–166.
  • MA JKC, HIATT A, HEIN M et al.: Generation and assembly of secretory antibodies in plants. Science (1995) 268(5211):716–719.
  • ••This paper showed that tobacco plants could produce and assemble functional secretory antibodies, which have four different components and ten polypeptide chains in all. Even in mammals, two different cell types are required to produce such molecules.
  • LARRICK JW, YU L, NAFTZGER C, JAISWAL S, WYCOFF K: Production of secretory IgA antibodies in plants. Biomolecular Eng. (2001) 18(3):87–94.
  • CHARGELEGUE D, VINE ND, VAN DOLLEWEERD CJ, DRAKE PMW, MA JKC: A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Res. (2000) 9(3):187–194.
  • WARNER TG: Metabolic engineering glycosylation: biotechnology's challenge to the glycobiologist in the new millennium. In: Carbohydrates in Chem. Biol. Ernst B, Hart GW, Sanay P (Eds.), Wiley-VCH, NY (2000):1043–1064.
  • BLIXT O, ALLIN K, PEREIRA L, DATTA A, PAULSON JC: Efficient chemoenzymatic synthesis of 0-linked sialyl oligosaccharides. J. Am. Chem. Soc. (2002) 124(20):5739–5746.
  • BAKKER H, BARDOR M, MOLTHOFF JW et al: Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl Acad. Sci. USA (2001) 98(5):2899–2904.
  • •In this report, the co-expression of a mammalian glactosyltransferase allows plants to produce recombinant antibodies with galactose residues on their glycan chains. The proportion of antibodies bearing the galactose residues was similar to that seen in mammalian expression systems.
  • SHAH MM, FUJIYAMA K, FLYNN CR, JOSHI L: Sialylated endogenous glycoconjugates in plant cells. Nat. BiotechnoL (2003) 21(12):1470–1471.
  • •This is the first report suggesting that plants may have the ability to add sialic acid residues to recombinant proteins. The veracity of the data has been challenged (see refs [103] and [1041).
  • SEVENO M, BARDOR M, PACCALET T, GOMORD LEROUGE P, FAYE L: Glycoprotein sialylation in plants? Nat. BiotechnoL (2004) 22(10:1351–1352.
  • SHAH MM, FUJIYAMA K, FLYNN CR, JOSHI L: Glycoprotein sialylation in plants? Reply. Nat. BiotechnoL (2004) 22(11):1352–1353.
  • STRASSER R, ALTMANN F, MACH L, GLOSSL J, STEINKELLNER H: Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alphal,3-linked fitcose. FEBS Lett. (2004) 561(1-3):132–136.
  • ••An exciting report showing that gene targeting strategies can be used to eliminate the enzymes responsible for adding nonmammalian carbohydrate residues to the glycans of recombinant glycoproteins produced in plants.
  • DECKER EL, RESKI R: The moss bioreactor. Curr. Opin. Plant Biol. (2004) 7(2):166–170.
  • FDA. Guidance for industry. Drugs, biologics, and medical devices derived from bioengineered plants for use in humans and animals. Food and Drug Administration (2002).
  • CPMP. Point to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants (CPMP/BWP/764/02), The European Agency for the Evaluation of Medicinal Products (EMEA) (2002).
  • TACKABERRY ES, PRIOR F, BELL M et al.: Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. Genome (2003) 46(3):521–526.
  • HARE PD, CHUA NH: Excision of selectable marker genes from transgenic plants. Nat. BiotechnoL (2002) 20(6):575–580.
  • KLAUS SMJ, HUANG FC, GOLDS TJ, KOOP H: Generation of marker-free plastid transformants using a transiently cointegrated selection gene. Nat. BiotechnoL (2004) 22(2):225–229.
  • LANGEVELD JP, BRENNAN FR, MARTINEZ-TORRECUADRADA JL et al.: Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine (2001) 19(27):3661–3670.
  • CARRILLO C, WIGDOROVITZ A OLIVEROS JC et al.: Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. ViroL (1998) 72(2):1688–1690.
  • CARRILLO C, WIGDOROVITZ A, TRONO K et al.: Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Viral Immunol. (2001) 14(1):49–57.
  • ZHOU JY, WU JX, CHENG LQ et al.: Expression of immunogenic 51 glycoprotein of infectious bronchitis virus in transgenic potatoes. J. ViroL (2003) 77(10:9090–9093.
  • ZHOU JY, CHENG LQ, ZHENG XJ et al.: Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus. J. BiotechnoL (2004) 111(2):121–130.
  • DALSGAARD K, UTTENTHAL A, JONES TD et al.: Plant-derived vaccine protects target animals against a viral disease. Nat. BiotechnoL (1997) 15(3):248–252.
  • KOO M, BENDAHMANE M, LETTIERI GA et al.: Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc. NatL Acad. Sci. USA (1999) 96(14):7774–7779.
  • FERNANDEZ-FERNANDEZ MR, MOURINO M, RIVERA J, RODRIGUEZ R, PLANA-DURAN J, GARCIA JA: Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector. Virology (2001) 280(2):283–291.
  • CASTANON S, MARIN MS, MARTIN-ALONSO JM et al.: Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J. ViroL (1999) 73(5):4452–4455.
  • LAMPHEAR BJ, STREATFIELD SJ, JILKA JM et al.: Delivery of subunit vaccines in maize seed. J. Control. Release (2002) 85(1-3):169–180.
  • TACKET CO, PASETTI MF, EDELMAN R, HOWARD JA, STREATFIELD S: Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine (In Press).
  • GAVILONDO JV, LARRICK JW: Antibody production technology in the millennium. Biotechniques (2000) 29(1):128–145.
  • MA JKC, HIKMAT BY, WYCOFF K et al: Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. (1998) 4(5):601–606.
  • ••A secretory antibody is described which can prevent dental caries after topical application in the oral cavity by preventing the pathogen responsible for this disease - Streptococcus mutans - from colonising the tooth surface.
  • McCORMICK AA, KUMAGAI MH, HANLEY K et al.: Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fir epitopes in tobacco plants. Proc. Natl. Acad. Sci. USA (1999) 96(2):703–708.
  • STOGER E, SACK M, NICHOLSON L, FISCHER R, CHRISTOU P: Recent progress in plantibody technology. Pharmaceutical Design (In Press).
  • FAHRNER RL, KNUDSEN HL, BASEY CD et al.: Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography processes. Biotechnol. Genet. Eng. Rev. (2001) 18:301–327.
  • BAI Y, GLATZ CE: Bioprocess considerations for expanded-bed chromatography of crude canola extract: sample preparation and adsorbent reuse. BiotechnoL Bioeng. (2003) 81(7):775–782.
  • KAPILA J, DERYCKE R, VANMONTAGU M, ANGENON G: An Agrobacterium-mediated transient gene expression system for intact leaves. Plant Sci. (1997) 122(1):101–108.
  • VAQUERO C, SACK M, SCHUSTER F et al.: A carcinoembryonic antigen-specific diabody produced in tobacco. FASEB J. (2002) 16(1):408–410.
  • VOINET O, RIVAS S, MESTRE P, BAULCOMBE D: An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant-J. (2003) 33(5):949–956.
  • D'AOUST MA, LEROUGE P, BUSSE U et al.: Efficient and reliable production of pharmaceuticals in alfalfa. In: Molecular Farming: Plant-made Pharmaceuticals and Technical Proteins. Fischer R, Schillberg S (Eds.). John Wiley & Sons, NY (In Press).
  • VERCH T, YUSIBOV V, KOPROWSKI H: Expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector./ ImmunoL Methods (1998) 220(1-2):69–75.
  • MOR TS, MASON HS: Plants as a source of subunit vaccines. In: Handbook of Plant Biotechnology (Volume 2). Christou P, Klee H (Eds.) Wiley-VCH, NY (2004):769–780.
  • LOMONOSSOFF GP, HAMILTON WD: Cowpea mosaic virus-based vaccines. Cuff. Thp. MicrobioL ImmunoL (1999) 240:177–189.
  • PORTA C, LOMONOSSOFF GP: Viruses as vectors for the expression of foreign sequences in plants. Biotechnol. Genet. Eng. Rev. (2002) 19:245–291.
  • DORAN PM: Foreign protein production in plant tissue cultures. Curr. Opin. Biotechnol. (2000) 11(2):199–204.
  • FISCHER R, EMANS N, SCHUSTER F, HELLWIG S, DROSSARD J: Towards molecular farming in the future: using plant-cell-suspension cultures as bioreactors. Biotechnol. AppL Biochem. (1999) 30(2):109–112.
  • HELLWIG S, DROSSARD J, TWYMAN RM, FISCHER R: Plant cell cultures for the production of recombinant proteins. Nat. Biotechnol. (2004) 22(11):1415–1422.
  • •A recent review which provides details of how plant cell cultures can be used to produce recombinant pharmaceutical proteins.
  • GASDASKA JR, SPENCER D, DICKEY L: Advantages of therapeutic protein production in the aquatic plant Lemna. Bioprocess J. (2003) 2(2):49–56.
  • MAYFIELD SP, FRANKLIN SE, LERNER RA: Expression and assembly of a fully active antibody in algae. Proc. NatL Acad. Sci. USA (2003) 100(2):438–442.
  • PEREZ FILGUEIRA DM, ZAMORANO PI, DOMINGUEZ MG et al.: Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine (2003) 21(27-30):4201–4209.
  • PEREZ FILGUEIRA DM, MOZGOVOJ M, WIGDOROVITZ A et al.: Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8 Produced in plants using a TMV-based vector. Arch. ViroL (In Press).
  • WIGDOROVITZ A, MOZGOVOJ M, SANTOS MJ et al.: Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants. J. Gen. ViroL (2004) 85(7):1825–1832.
  • GIL F, BRUN A, WIGDOROVITZ A, CATALA R et al.: High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett. (2001) 488(1-2):13–17.
  • NICHOLAS BL, BRENNAN FR, MARTINEZ-TORRECUADRADA JL, CASAL JI, HAMILTON WDO, WAKELIN D: Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses. Vaccine (2002) 20(21-22):2727–2734.
  • FERNANDEZ-FERNANDEZ MR, MARTINEZ-TORRECUADRADA JL, CASAL JI, GARCIA JA: Development of an antigen presentation system based in the plum pox potyvirus. FEBS Lett. (1998) 427(2):229–235.
  • MOLINA A, HERVA-STUBBS S, DANIELL H, MINGO-CASTEL AM, VERAMENDI J: High yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. (2004) 2(2):141–153.
  • JOENSUU JJ, KOTIAHO M, RIIPI T et al.: Fimbrial subunit protein FaeG expressed in transgenic tobacco inhibits the binding of F4ac enterotoxigenic Escherichia coli to porcine enterocytes. Transgenic Res. (2004) 13(3):295–298.
  • WIGDOROVITZ A, CARRILLO C, DUS SANTOS MJ et al.: Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology (1999) 255(2):347–353.
  • DUS SANTOS MJ, WIGDOROVITZ A, TRONO K et al.: A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine (2002) 20(7-8):1141–1147.
  • USHA R, ROHLL JB, SPALL VE, SHANKS M et al.: Expression of an animal virus antigenic site on the surface of a plant-virus particle. Virology (1993) 197(1):366–374.
  • LEE RW, STROMMER J, HODGINS D, SHEWEN PE, NIU Y, LO RY: Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica Al leukotoxin 50 fusion protein. Infect. Immun. (2001) 69(9):5786–5793.
  • BAE JL, LEE JG, KANG TJ, JANG HS, JANG YS, YANG MS: Induction of antigen specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen. Vaccine (2003) 21(25-26):4052–4058.
  • SATYAVATHI VV, PRASAD V, KHANDELWAL A, SHAILA MS, SITA GL: Expression of hemagglutinin protein of Rinderpest virus in transgenic pigeon pea [Cajanus cajan (L.) Millsp.] plants. Plant Cell Rep. (2003) 21(7):651–658.
  • GOMEZ N, CARRILLO C, SALINAS J, PARRA F, BORCA MV, ESCRIBANO JM: Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology (1998) 249(2):352–358.
  • TUBOLY T, YU W, BAILEY A et al.: Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine (2000) 18(19):2023–2028.
  • GOMEZ N, WIGDOROVITZ A, CASTANON S et al.: Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch. Virol. (2000) 145(8):1725–1732.
  • AZIZ MA, SINGH S, KUMAR PA, BHATNAGAR R: Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem. Biophys. Res. Commun. (2002) 299(3):345–351.
  • DA SILVA JV, GARCIA AB, FLORES VMQ, DE MACEDO ZS, MEDINA-ACOSTA E: Phytosecretion of enteropathogenic Escherichia coli pilin subunit A in transgenic tobacco and its suitability for early life vaccinology. Vaccine (2002) 20(161:2091–2101.
  • CHIKWAMBA R, CUNNICK J, HATHAWAY D, MCMURRAY J, MASON H, WANG K: A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res. (2002) 11(5):479–493.
  • STREATFIELD SJ, JILKA JM, HOOD EE et al.: Plant-based vaccines: unique advantages. Vaccine (2001) 19(17-19):2742–2748.
  • HAQ TA, MASON HS, CLEMENTS JD, ARNTZEN CJ: Oral immunization with a recombinant bacterial-antigen produced in transgenic plants. Science (1995) 268(5211):714–716.
  • MASON HS, HAQ TA, CLEMENTS JD, ARNTZEN CJ: Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine (1998) 16(13):1336–1343.
  • LAUTERSLAGER TG, FLORACK DE, VAN DER WAL TJ et al.: Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine (2001) 19(17-19) :2749–2755.
  • YU J, LANGRIDGE WH: A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. BiotechnoL (2001) 19(0:548–552.
  • ••This paper describes a plant-produced vaccine which is a fusion protein eliciting an immune response against three unrelated pathogens simultaneously.
  • JUDGE NA, MASON HS, O'BRIEN AD: Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli 0157:H7 shedding in feces. Infect. ImmunoL (2004) 72(1):168–175.
  • GAO Y, MA Y, LI M et al.: Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. World J. GastroenteroL (2003) 9(5):996–1002.
  • KONG QX, RICHTER L, YANG YF, ARNTZEN CJ, MASON HS, THANAVALA Y: Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Nail. Acad. Sci. USA (2001) 98(2011539–11544.
  • EHSANI P, KHABIRI A, DOMANSKY NN: Polypeptides of hepatitis B surface antigen produced in transgenic potato. Gene (1997) 190(1):107–111.
  • SMITH ML, KEEGAN ME, MASON HS, SHULER ML: Factors important in the extraction, stability and in vitro assembly of the hepatitis B surface antigen derived from recombinant plant systems. BiotechnoL Prog-. (2002) 18(3):538–550.
  • MASON HS, LAM DMK, ARNTZEN CJ: Expression of hepatitis-B surface-antigen in transgenic plants. Proc. Nail. Acad. Sci. USA (1992) 89(24):11745–11749.
  • THANAVALA Y, YANG YF, LYONS P, MASON HS, ARNTZEN C: Immunogenicity of transgenic plant-derived hepatitis-B surface-antigen. Proc. Natl. Acad. Sci. USA (1995) 92(8):3358–3361.
  • SOJIKUL P, BUEHNER N, MASON HS: A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc. Natl. Acad. Sci. USA (2003) 100(5):2209–2214.
  • NATILLA A, PIAZZOLLA G, NUZZACHI A et al.: Cucumber mosaic virus as a carrier of hepatitis C virus-derived epitope. Arch. ViroL (2004) 149(1):137–154.
  • NEMCHINOV LG, LIANG TJ, RIFAAT MM, MAZYAD HM, HADIDI A, KEITH JM: Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch. ViroL (2000) 145(12):2557–2573.
  • MA Y, LIN SQ, GAO Y et al.: Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products. World J. Gastroenterol. (2003) 9(10):2211–2215.
  • TACKABERRY ES, DUDANI AK, biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine (1999) 17(23-24):3020–3029.
  • ZHANG G, LEUNG C, MURDIN L, ROVINSKI B, WHITE KA: In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector. MoL BiotechnoL (2000) 14(2):99–107.
  • ZHANG G, RODRIGUES L, ROVINSKI B, WHITE KA: Production of HIV-1 p24 protein in transgenic tobacco plants. MoL BiotechnoL (2002) 20(2):131–136.
  • YUSIBOV V, MODELSKA A, STEPLEWSKI K et al.: Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl. Acad. Sci. USA (1997) 94(11):5784–5788.
  • JOELSON T, AKERBLOM L, OXELFELT P, STRANDBERG B, TOMENIUS K, MORRIS TJ: Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J. Gen. ViroL (1997) 78(6):1213–1217.
  • MARUSIC C, PIZZA P, LATTANZI L et al.: Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus Type 1.1 ViroL (2001) 75(108434–8439.
  • WARZECHA H, MASON HS, LANE C et al.: Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. ViroL (2003) 77(10:8702–8711.
  • FRANCONI R, DI BONITO P, DIBELLO F et al.: Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection. Cancer Res. (2002) 62(13):3654–3658
  • VARSANI A, WILLIAMSON AL, ROSE RC, JAFFER M, RYBICKI EP: Expression of human papillomavirus Type 16 major capsid protein in transgenic IVicotiana tabacum cv. Xanthi. Arch. ViroL (2003) 148(9):1771–1786.
  • BIEMELT, S, SONNEWALD U, GALMBACHER P, WILLMITZER L, MULLER M: Production of human papillomavirus Type 16 virus-like particles in transgenic plants. J. ViroL (2003) 77(17):9211–9220.
  • PORTA C, SPALL VE, LOVELAND J, JOHNSON JE, BARKER PJ, LOMONOSSOFF GP: Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology (1994) 202(1-2):949–955.
  • HUANG Z, DRY I, WEBSTER D, STRUGNELL R, WESSELINGH S: Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. Vaccine (2001) 19(15-16):2163–2171.
  • WEBSTER DE, COONEY ML, HUANG ZJ et al.: Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine. J. ViroL (2002) 76(15):7910–7912.
  • MASON HS, BALL JM, SHI JJ, JIANG X, ESTES MK, ARNTZEN CJ: Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Nail. Acad. Sci. USA (1996) 93(11):5335–5340.
  • GHOSH S, MALHOTRA P, LALITHA PV, GUHA-MUKHERJEE S, CHAUHAN VS: Expression of Plasmodium falciparum C-terminal region of merozoite surface protein (PfMSP1(19)), a potential malaria vaccine candidate, in tobacco. Plant Sci. (2002) 162(3):335–343.
  • TURPEN TH, REINL SJ, CHAROENVIT Y, HOFFMAN SL, FALLARME V, GRILL LK: Malarial epitopes expressed on the surface of recombinant tobacco mosaic-virus. Bio/Technology (1995) 13(1):53–57.
  • GILLELAND HE, GILLELAND LB, STACZEK J et al: Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. FEMS ImmunoL Med. MicrobioL (2000) 27(4):291–297.
  • BRENNAN FR, JONES TD, GILLELAND LB et al: Psuedemonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology (1999) 145(1):211–220.
  • STACZEK J, BENDAHMANE M, GILLELAND LB, BEACHY RN, GILLELAND HE Jr: Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with I? aeruginosa. Vaccine (2000) 18(21):2266–2274.
  • YUSIBOV V, MODELSKA A, STEPLEWSKI K et al: Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl Acad. Sci. USA (1997) 94(11):5784–5788.
  • MODELSKA A, DIETZSCHOLD B, SLEYSH N et al: Immunization against rabies with plant-derived antigen. Proc. Natl Acad. Sci. USA (1998) 95(5):2481–2485.
  • BELANGER H, FLEYSH N, COX S et al.: Human respiratory syncytial virus vaccine antigen produced in plants. FASEB J. (2000) 14(14):2323–2328.
  • ARAKAWAT, YU J, LANGRIDGE WHR: Synthesis of a cholera toxin B subunit-rotavirus NSP4 fusion protein in potato. Plant Cell Rep. (2001) 20(0343–348.
  • MATSUMURA T, ITCHODA N, TSUNEMITSU H: Production of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants. Arch. ViroL (2002) 147(6):1263–1270.
  • CHUNG IS, KIM CH, KIM KI et al: Production of recombinant rotavirus VP6 from a suspension culture of transgenic tomato (Lycopersicon esculentum Mill.) cells. BiotechnoL Lett. (2000) 22(4):251–255.
  • KIM CH, KIM KI, HONG SH, LEE YH, CHUNG IS: Improved production of recombinant rotavirus VP6 in sodium butyrate-supplemented suspension cultures of transgenic tomato (Lycopersicon esculentum Mill.) cells. BiotechnoL Lett. (2001) 23(13):1061–1066.
  • O'BRIEN GJ, BRYANT CJ, VOOGD C, GREENBERG HB, GARDNER RC, BELLAMY AR: Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into virus-like particles. Virology (2000) 270(2):444–453.
  • WU YZ, LI JT, MOU ZR et al: Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. Virology (2003) 313(2):337–342.
  • KIM TG, RUPRECHT R, LANGRIDGE WH: Synthesis and assembly of a cholera toxin B subunit SHIV 89.6p Tat fusion protein in transgenic potato. Protein Expr. Purif (2004) 35(2):313–319.
  • BRENNAN FR, JONES TD, LONGSTAFF M et al.: Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 17(15-10:1846–1857.
  • ARAKAWA T, CHONG DK, MERRITT JL, LANGRIDGE WH: Expression of cholera B subunit oligomers in transgenic potato plants. Transgenic Res. (1997) 6(6):403–413.
  • ARAKAWA T, CHONG DK, LANGRIDGE WH: Efficacy of food plant-based oral cholera toxin B subunit vaccine. Nat. BiotechnoL (1998) 16(3):292–297.
  • KANG TJ, LOG NH, JANG MO, YANG MS: Modification of the cholera toxin B subunit coding sequence to enhance expression in plants. MoL Breeding (2004) 13(12)143–153.
  • JANI D, MEENA LS, RIZWAN-UL-HAW QM, SINGH Y, SHARMA AK, TYAGI AK: Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res. (2002) 11(5):447–454.
  • VAQUERO C, SACK M, CHANDLER J et al.: Transient expression of a tumor-specific single chain fragment and a chimeric antibody in tobacco leaves. Proc. NatL Acad. Sci. USA (1999) 96(20):11128–11133.
  • TORRES E, VAQUERO C, NICHOLSON L et al.: Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res. (1999) 8(6):441–449.
  • FRANCISCO JA, GAWLAK SL, MILLER M et al.: Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture. Bioconjugate Chem. (1997) 8(5):708–713.
  • DE NEVE M, DE LOOSE M, JACOBS A et al.: Assembly of an antibody and its derived antibody fragment in Nicotiana and Arabidopsis. Transgenic Res. (1993) 2(4):227–237.
  • DE WILDE C, DE NEVE M, DE RYCKE R et al.: Intact antigen-binding MAK33 antibody and Fab fragment accumulate in intercellular spaces of Arabidopsis thaliana. Plant Sci. (1996) 114(2):233–241.
  • BOUQUIN T, THOMSEN M, NIELSEN LK, GREEN TH, MUNDY J, HANEFELD DZIEGIEL M: Human anti-rhesus D IgG1 antibody produced in transgenic plants. Transgenic Res. (2002) 11(2):115–122.
  • SEMENYUK EG, ORLOVA IV, STREMOVSKII OA et al.: Transgenic tobacco plants produce miniantibodies against human ferritin. DokL Biochem. Biophys. (2002) 384:176–178.
  • RAMIREZ N, RODRIGUEZ M, AYALA M et al.: Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen. BiotechnoL AppL Biochem. (2003) 38(3):223–230.
  • VALDES R, REYES B, ALVAREZ T et al.: Hepatitis B surface antigen immunopurification using a plant-derived specific antibody produced in large scale. Biochem. Biophys. Res. Commun. (2003) 310(3):742–747.
  • KATHURIA S, SRIRAMAN R, SACK M et al: Efficacy of plant-produced recombinant antibodies against HCG. Hum. Reprod. (2002) 17(8):2054–2061.
  • EHSANI P, MEUNIER A, NATO F, JAFARI A, NATO A, LAFAYE P: Expression of anti human IL-4 and IL-6 scEvs in transgenic tobacco plants. Plant MoL BioL (2003) 52(1):17–29.
  • VINE ND, DRAKE P, HIATT A, MA JKC: Assembly and plasma membrane targeting of recombinant immunoglobulin chains in plants with a murine immunoglobulin transmembrane sequence. Plant MoL Biol. (2001) 45(2):159–167.
  • BENVENUTO E, ORDAS RJ, TAVAZZA R et al.: `Phytoantibodies': A general vector for the expression of immunoglobulin domains in transgenic plants. Plant MoL Biol. (1991) 17(4):865–874.
  • PETOLINO JE, YOUNG S, HOPKINS N et al: Expression of murine adenosine deaminase (ADA) in transgenic maize. Transgenic Res. (2000) 9(1):1–9.
  • HAMAMOTO H, SUGIYAMA Y, NAKAGAWA N et al.: A new tobacco mosaic virus vector and its use for the systemic production of angiotensin I converting enzyme-inhibitor in transgenic tobacco and tomato. Bio/Technology (1993) 11(8):930–932.
  • ZHONG GY, PETERSON D, DELANEY DE et al.: Commercial production of aprotinin in transgenic maize seeds. MoL Breeding (1999) 5(0345–356.
  • RUGGIERO F, EXPOSITO JY BOURNAT P et al.: Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett. (2000) 469(1):132–136.
  • •This paper shows the ability of plants to produce structural proteins, in this case human collagen, with applications in cosmetic surgery and tissue repair.
  • MERLE C, PERRET S, LACOUR T et al: Hydroxylated human homotrimeric collagen Tin Agrobacterium tumefaciens-mediated transient expression and in transgenic tobacco plant. FEBS Lett. (2002) 515(1-3):114–118.
  • ••In a follow-up to ref [228], the expression of of a modifying enzyme allows the production of human collagen in its native form, as a hydroxylated homotrimer.
  • VANDEKERCKHOVE J, VANDAMME J, VANLIJSEBETTENS M et al.: Enkephalins produced in transgenic plants using modified 2S seed storage proteins. Bio/Technology (1989) 7(9):929–932.
  • HIGO K, SAITO Y, HIGO H: Expression of a chemically synthesized gene for human epidermal growth factor under the control of cauliflower mosaic virus 35S promoter in transgenic tobacco. Biosci. Biotech. Biochem. (1993) 57(9):1477–1481.
  • WIRTH S, CALAMANTE G, MENTABERRY A et al.: Expression of active human epidermal growth factor (hEGF) in tobacco plants by integrative and non-integrative systems. MoL Breeding (2004) 13(12):23–35.
  • MATSUMOTO S, IKURA K, UEDA M, SASAKI R: Characterisation of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Plant MoL Biol. (1995) 27(6):1163–1172.
  • GAO J, HOOKER BS, ANDERSON DB: Expression of functional human coagulation Factor XIII A-domain in plant cell suspensions and whole plants. Protein Expr. Purif (2004) 37(1):89–96.
  • AVESANI L, FALORNI A, TORNIELLI GB et al.: Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65). Transgenic Res. (2003) 12(2):203–212.
  • CRAMER CL, WEISSENBORN DL, OISHI KK et al: Bioproduction of human enzymes in transgenic tobacco. Ann. NY Acad. Sci. (1996) 792:62–71.
  • LEITE A, KEMPER E, DA SILVA M et al.: Expression of correctly processed human growth hormone in seeds of transgenic tobacco plants. MoL Breeding (2000) 6(1):47–53.
  • DIERYCK W, PAGNIER J, POYART C et al.: Human haemoglobin from transgenic tobacco. Nature (1997) 386(6620):29–30.
  • PARMENTER DL, BOOTHE JG, VANROOIJEN GJH, YEUNG EC, MOLONEY MM: Production of biologically active hirudin in plant seeds using oleosin partitioning. Plant MoL Biol. (1995) 29(6):1167–1180.
  • PANAHI M, ALLI Z, CHENG X et al.: Recombinant protein expression plasmids optimized for industrial E. coli fermentation and plant systems produce biologically active human insulin-like growth factor-1 in transgenic rice and tobacco plants. Transgenic Res. (2004) 13(3):245–259.
  • PARK Y, CHEONG H: Expression and production of recombinant human interleukin-2 in potato plants. Protein Express. Purif (2002) 25(1):160–165.
  • MA S, HUANG Y, YIN Z, MENASSA R, BRANDLE JE, JEVNIKAR AM: Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. Proc. Nail Acad. Sci. USA (2004) 101(15):5680–5685.
  • MENASSA R, KENNETTE W, NGUYEN V, RYMERSON R, JEVNIKAR A, BRANDLE J: Subcellular targeting of human interleukin-10 in plants. J. BiotechnoL (2004) 108(2):179–183.
  • GUTIERREZ-ORTEGA A, AVILA-MORENO F, SAUCEDO-ARIAS LJ, SANCHEZ-TORRES C, GOMEZ-LIM MA: Expression of a single-chain human interleukin-12 gene in transgenic tobacco plants and functional studies. BiotechnoL Bioeng. (2004) 85(7):734–740.
  • TURCHINOVICH AA, DEINEKO EV, FILIPENKO ML et al.: Transgenic tobacco plants producing human interleukin-18. DokL Biochem. Biophys. (2004) 395:104–107.
  • FEDOSOV SN, LAURSEN NB, NEXO E, MOESTRUP SK et al.: Human intrinsic factor expressed in the plant Arabidopsis thaliana. Eur. j Biochem. (2003) 270(10:3362–3367.
  • SUZUKI YA, KELLEHER SL, YALDA D et al.: Expression, characterization, and biologic activity of recombinant human lactoferrin in rice. J. Pediatr. GastroenteroL Num (2003) 36(2):190–199.
  • HUMPHREY BD, HUANG N, KLASING KC: Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks. J. Num. (2002) 132(6):1214–1218.
  • LI Y, GENG Y, SONG H, ZHENG G, HUAN L, QIU B: Expression of a human lactoferrin N-lobe in IVicotiana benthmiana [sic] with potato virus X-based agroinfection. BiotechnoL Lett. (2004) 26(12):953–957.
  • YANG D, GUO F, LIU B, HUANG N, WATKINS SC: Expression and localization of human lysozyme in the endosperm of transgenic rice. Planta (2003) 216(4):597–603.
  • HUANG J, WU L, YALDA D et al.: Expression of functional recombinant human lysozyme in transgenic rice cell culture. Transgenic Res. (2002) 11(3):229–239.
  • GRUBER V BERNA PP, ARNAUD T et al: Large-scale production of a therapeutic protein in transgenic tobacco plants: effect of subcellular targeting on quality of a recombinant dog gastric lipase. MoL Breeding (2001) 7(4):329–340.
  • FARRAN I, SANCHEZ-SERRANO JJ, MEDINA JF, PRIETO J, MINGO-CASTEL AM: Targeted expression of human serum albumin to potato tubers. Transgenic Res. (2002) 11(4):337–436.
  • MORASSUTTI C, DE AMICIS F, SKERLAVAJ B, ZANETTI M, MARCHETTI S: Production of a recombinant antimicrobial peptide in transgenic plants using a modified VMA intein expression system. FEBS Lett. (2002) 519(1-3):141–146.
  • GUDA C, LEE SB, DANIELL H: Stable expression of a biodegradable protein-based polymer in tobacco chloroplasts. Plant Cell Rep. (2000) 19(3):257–262.
  • ZHU Z, HUGHES KW, HUANG L et al.: Expression of human alpha-interferon cDNA in transgenic rice plants. Plant Cell Tiss. Org. Cult. (1994) 36(2):197–204.
  • KUMAGAI MH, TURPEN TH, WEINZETTL N et al.: Rapid, high-level expression of biologically-active alpha-trichosanthin in transfected plants by an RNA viral vector. Proc. Natl. Acad. Sci. USA (1993) 90(2):427–430.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.